Hansard
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 15 of 66
View Gudie Hutchings Profile
Lib. (NL)
View Gudie Hutchings Profile
2020-07-08 16:36 [p.2577]
Mr. Speaker, it is always a pleasure to listen to my friend and colleague from Saanich—Gulf Islands. I am on one coast of this country and she is on the other.
I have been in Ottawa the last couple of days with another colleague on FEWO, the status of women meetings. We heard very clearly the impact that COVID-19 has had on women from coast to coast to coast: indigenous women, women of colour, women in the new work force and women in the old work force. We also heard the finance minister make mention today of the severe impact that COVID-19 is having on women in our country.
I would like to ask my hon. colleague, going forward as we look down the road to recovery, what advice she has for the Minister for Women and Gender Equality on how to get women back on a level playing field and how to get our economy going? We know that women will be a good part of it.
View Churence Rogers Profile
Lib. (NL)
Madam Speaker, it is a pleasure to rise today to discuss the motion tabled by the member for Vancouver Kingsway related to pharmacare. I too will be supporting this motion, because I believe and our government recognizes that the cost of drugs can directly affect the lives of Canadians.
Families should not have to choose between putting food on the table and paying for the drugs they need. That is why we have committed to implementing universal pharmacare to ensure that all Canadians have equitable and affordable access to the medicines they need.
Today I would like to highlight how the federal government is supporting innovative research to advance drug discovery and develop new therapies to improve the health of Canadians.
The Canadian Institutes of Health Research is the main federal agency responsible for funding health research across Canada. Every year the Government of Canada, through this group, invests over $1 billion in research initiatives that will generate new knowledge and evidence and lead to better and more affordable treatments for Canadians. Clinical trials are the cornerstone of an evidence-based practice and ensure timely access to new drugs and treatments for Canadians.
In 2016, CIHR launched the innovative clinical trials initiative. With an annual investment of $11.7 million, this initiative is supporting research focused on the development and implementation of innovative methods in clinical research. This specific initiative is part of the larger strategy for patient-oriented research, a national coalition of federal, provincial and territorial partners dedicated to the integration of research into care.
The SPOR innovative clinical trials initiative will contribute to increasing Canadian competitiveness in innovative clinical trials research and provide a stimulus for researchers to adopt new methodologies to conduct clinical trials. It will also encourage collaboration with various stakeholders, including patients, decision-makers and key stakeholders.
Innovative clinical trials use designs that are alternative to traditional trials methodologies. These new methods can reduce the cost of conducting trials, reduce the amount of time needed to answer research questions and increase the relevance of research findings to patients, health care providers and policy-makers. The direct outcome of these new methods is improved effectiveness of the trials while keeping the same high safety and effectiveness standards for the drugs. This will result in lowering the cost of drug development, ensuring that new, affordable and effective drugs are available for Canadians.
As part of this initiative, CIHR is supporting the CLEAN Meds project, led by researchers at Unity Health Toronto. Through a randomized controlled trial, researchers are investigating the effects of providing patients with free and convenient access to a selected set of medications. Each person is randomly assigned to either receive usual access to medications or to receive access to essential medications at no cost.
Preliminary findings from the CLEAN Meds trial demonstrate that the distribution of essential medicines at no charge for one year increased adherence to treatment medicines and improved some disease-specific health outcomes. These findings could help inform changes to medicine access policies such as publicly funding essential medicines.
Through the innovative clinical trials initiative, CIHR is also supporting a team led by Dr. Jacob Udell at the Women's College Hospital in Toronto. This work is looking at ways of leveraging big data to facilitate recruitment of patients in clinical trials, measurement of patient characteristics and follow-up of patient outcomes. It is expected that this approach will transform how clinical trials are conducted in Canada, which would ultimately contribute to lower drug development costs.
Leading researchers across the country are also conducting research to improve the safety and effectiveness of drugs. For example, CIHR is supporting a research project led by Dr. Michal Abrahamowicz at McGill University that aims to improve monitoring of adverse drug reactions. While most new drugs help improve patients' health, some may have important unintended side effects and others may be less effective than existing drugs. This research will allow for the development of new statistical methods that will allow for more accurate assessments of the safety and effectiveness of different drugs used by Canadians, and help to reduce the risk of serious adverse events.
Of course, underpinning all of this research are CIHR's research investments into the development of new drugs and therapies. For example, through CIHR's investigator-initiated programs, our government is investing $4.7 million in a research program led by Dr. Hanns Lochmüller at the Children's Hospital of Eastern Ontario Research Institute, right here in Ottawa, to discover and test several new therapies to treat neuromuscular diseases. Over 50,000 Canadians have a neuromuscular disease, of which there are over 150 types. Neuromuscular disease is associated with progressive muscle weakness, disability and early death, and can cause significant economic burdens on families that are affected.
Through his research, Dr. Lochmüller is using a combination of genomics, molecular biology, animal models and clinical trials to improve the diagnosis and treatment of neuromuscular disease. His objectives are to reveal the genetic mechanisms of 20 new genes associated with neuromuscular diseases, discover five new therapies and study seven therapies, four of which were repurposed and three new. The hope is that this research will lead to new ways to treat neuromuscular diseases.
Through the Canada research chairs program, CIHR is also supporting research led by Dr. Weihong Song at the University of British Columbia on Alzheimer's disease. Dementia has a significant and growing impact in Canada. We know that there are more than 419,000 Canadians aged 65 and older diagnosed with dementia. The impact of dementia on individuals, their families and the health care system is significant. In the absence of a cure or effective therapy, the total annual health care costs and out-of-pocket caregiver costs for Canadians with dementia are expected to exceed $16 billion by 2031. As the Canada Research Chair in Alzheimer's Disease, Dr. Song is studying the cause of dementia found in Alzheimer's disease and working to discover new drugs targeting Alzheimer's disease.
CIHR is also supporting groundbreaking research by Dr. Mick Bhatia at McMaster University in the hopes of uncovering new treatments for leukemia, a cancer that starts in blood stem cells.
Our government is committed to accelerating medical breakthroughs for people affected by rare diseases. Approximately one million people are affected by more than 7,000 different rare diseases in Canada. These diseases often appear at birth or emerge in early childhood. One-third of children with rare diseases die before their fifth birthday. For the vast majority of these conditions, there is no treatment available.
Canada, through CIHR and Genome Canada, is a founding member of the International Rare Diseases Research Consortium, which was established in April 2011 with a goal to develop 200 new therapies for rare diseases by 2020. I am pleased to note that the consortium had surpassed this target a few years early, with over 279 new medicinal products and therapies for rare diseases developed by 2017.
To conclude, I would like to reiterate that ensuring equitable access to necessary medicines is a priority for our government.
View Churence Rogers Profile
Lib. (NL)
Madam Speaker, we know we are embarking on a path toward universal pharmacare for this country, and our government believes it is necessary to support Canadians. As to how it will roll out in the provinces and territories, a whole set of negotiations and discussions need to be had before anybody can commit to what it might look like going forward.
View Churence Rogers Profile
Lib. (NL)
Madam Speaker, as I said at the outset, I will be supporting this motion.
View Churence Rogers Profile
Lib. (NL)
Madam Speaker, health care funding has been a priority of this government. We know, for example, that transfers to the provinces are nearly $42 billion. Since 2014, there has been an additional $10 billion going to provinces, much of it aimed at taking care of issues like mental health and home care services. Now we want to move to a universal pharmacare program. This government is committed to making that happen and I fully support it.
View Churence Rogers Profile
Lib. (NL)
Madam Speaker, I have spoken with many different groups and organizations, including pharmacists, and as I have stated very clearly, my position on universal pharmacare is that I support it and support what this government is trying to do.
View Yvonne Jones Profile
Lib. (NL)
View Yvonne Jones Profile
2020-03-12 14:07 [p.2012]
Mr. Speaker, I rise today to congratulate the organizers, sponsors, racers and volunteers of Cain's Quest 2020. Labrador is the home for Cain's Quest snowmobile race.
Through some of the most rugged and challenging lands in Canada's north, this race is one of tremendous endurance. Through 3,100 kilometres of land, over 19 checkpoints with 100 snowmobilers, it is one of the most enduring races on the planet today. This year, we also had two women's teams, one from Canada and the U.S. and one from Finland, and I want to give a big shout-out to them. Cain's Quest really pushes both the individual and the machine to the limits. It takes skill, stamina and determination.
I want to congratulate all those who took part and the winners of the cup, Rod Pye of Lodge Bay and Darryl Burdett of Cartwright, the Mighty Haulers, on their championship win in Cain's Quest.
View Churence Rogers Profile
Lib. (NL)
Mr. Speaker, my riding and communities across the country depend on the Canadian Coast Guard to keep our waterways safe and flowing all year round. Although we have been lucky with the light ice season this year, it has been detrimental to coastal communities in the past. Can the minister tell us how the Coast Guard is ensuring that our waters remain safe and open during the winter months?
View Gudie Hutchings Profile
Lib. (NL)
View Gudie Hutchings Profile
2020-03-11 18:33 [p.1969]
Madam Speaker, I would like to thank the member first and foremost for sharing her story and for providing the House with this opportunity to speak about mental health.
According to Statistics Canada, one in three Canadians will be affected by a mental illness in their lifetime. Mental health is influenced by a number of factors, including life experience and social and economic conditions. Our government recognizes the need for a comprehensive approach to mental health, one that embraces promotion and prevention alongside treatment and recovery.
For this reason, we have worked with our partners and stakeholders to put in place community-based programs and initiatives that promote mental health and contribute to the prevention of mental illness.
Our government is also committed to increasing the availability of high-quality mental health services for all Canadians. Through budget 2017, we provided provinces and territories with $5 billion over 10 years to improve access to mental health and addiction services. These targeted investments will address specific gaps in the availability of mental health services, including those for children and youth.
Allow me to illustrate, through concrete examples, how these investments are expected to directly help Canadians suffering from mental illness.
With this funding, in my province of Newfoundland and Labrador we will add new community crisis houses to provide a safe place for people experiencing a mental health crisis. Several models will be explored for these beds, based on the emerging needs of each of the province's regional health authorities.
Quebec will improve accommodation and community retention services to provide psychiatric hospitalizations and reduce psychiatric ward stays.
The Northwest Territories will contract an itinerant private counselling team that will provide surge capacity assistance to individuals struggling with mental illness through timely crisis supports when local resources are either unavailable or overwhelmed.
Saskatchewan will establish residential options that include intensive supports for individuals with serious and persistent mental health issues.
With federal funds, Ontario has committed to develop and provide new services in supportive units, such as daily living supports and case management for those living with mental illness, those with addictions, and those who are at risk of becoming homeless.
In Ontario, as well as in New Brunswick, Prince Edward Island, and Nova Scotia, federal investments will also support other initiatives that integrate mental health and addictions services into supportive housing programs, justice services, and education settings, all of which will have a particular focus on youth.
To provide support for those struggling with suicidal thoughts, our government is also investing close to $3 million over five years to support the development of the Canada suicide prevention service through Crisis Services Canada. This service connects people in Canada to confidential 24/7 crisis support and resources through trained responders.
Finally, to promote child and youth mental health, our government is also investing $1.1 million in 2019-20, $4.7 million in 2020-21 and $4.9 million from 2021-22 and onwards through the mental health promotion innovation fund. The fund will support the development of new and promising interventions that aim to address the underlying determinants of mental health in children and young people throughout Canada.
To sum up, mental health is a priority for the federal government, and we will continue to work with all our partners to make improvements in this area.
View Gudie Hutchings Profile
Lib. (NL)
View Gudie Hutchings Profile
2020-03-11 18:38 [p.1970]
Madam Speaker, I know my hon. colleague is passionate about this issue and I encourage her to reach out and work with all the departments.
I am sure the member knows that the provinces determine where most of the federal money given to them goes. That is why we were so adamant in earmarking that money for mental health initiatives.
We are committed to a comprehensive approach to mental health, one that embraces promotion, prevention, treatment and recovery. We are investing in a range of culturally appropriate mental health initiatives and programs that take into account social, economic and environmental factors, such as income, housing and education. We are also working with our provincial and territorial partners to improve access to mental health services for Canadians.
As mentioned, through our commitment of $5 billion over 10 years in budget 2017, investments have been made in appropriate and cost-effective mental health services for Canadians. We will ensure that the provinces continue to do so.
The challenge of addressing mental health issues requires the combined efforts of all levels of government and many stakeholders, as well as all members in this House.
View Gudie Hutchings Profile
Lib. (NL)
View Gudie Hutchings Profile
2020-03-11 18:52 [p.1972]
Madam Speaker, first and foremost, I would like to congratulate my colleague from Stormont—Dundas—South Glengarry for his recent election and passionately representing his constituents in the House. I too am from a very large rural riding. I love to say the land-mass of my riding is bigger than Switzerland. I have 217 beautiful little communities. Therefore, the member should come and visit the west coast of Newfoundland at any time.
The Government of Canada believes in the importance of investing in infrastructure. We believe in the promise we made to Canadians to create good jobs, grow the economy and invest in resilient and sustainable communities.
The over 52,000 projects across the country that we have supported through the investing in Canada plan are tangible proof of how we are delivering on that promise. Over 4,800 of those are right here in Ontario.
I am pleased to have the opportunity to talk about how we review the projects submitted for funding approval and to highlight how the federal funding is available now for provincial, territorial and municipal priorities. We want all Canadians to see and feel the impacts of the investments.
Under the majority of Canada's infrastructure programs, once the projects are approved, partners can start their projects and spend immediately. The flow of federal funds occurs when the claims are submitted to the department for reimbursement. We want to ensure that the projects are reviewed and approved as quickly as possible. That is why we continue to work closely with our partners to explore how we can improve the timeliness of our flow of funds.
Through the investing in Canada infrastructure program, we are investing over $33 billion across the country through bilateral agreements with each and every province and territory. The program investments all aim to improve the quality of life of Canadians by investing in infrastructure through four funding streams: public transit; green; community, culture and recreational; and rural and northern communities' infrastructure.
Specifically, the rural and northern communities' stream of the program dedicates $2 billion to addressing the unique infrastructure needs of these really rural and remote communities. Our investments are increasing economic growth and creating jobs within the infrastructure that improves peoples' quality of life. The investments are benefiting rural and remote communities across the country, but before a project can begin, an application has to be submitted.
Under this program, it is then up to provinces and territories to identify the projects, prioritize the projects and submit those projects for approval. Each application is then assessed to determine whether it fits within the applicable funding stream or whether federal environmental assessment or indigenous consultations are required.
By working closely with our partners, we are aiming to get shovels in the ground faster to deliver real results for Canadian communities.
I understand the member's question about during the writ period. I too was impacted by that, and that is just the way things go. During the writ period, nothing happens. If it is a sitting member, it is considered a feather in his or her cap, so to speak. That is why nothing goes on during the writ period.
In fairness to my colleague, as he is new in the House, it takes a while for the new departments to get staffed up and under way, especially when a new minister is in place.
I am proud of the work our government is doing to ensure our communities grow and succeed now and into the future. I look forward to working with my colleague anytime we can address this issue further.
View Gudie Hutchings Profile
Lib. (NL)
View Gudie Hutchings Profile
2020-03-11 18:57 [p.1973]
Madam Speaker, as I mentioned, we are investing $33 billion through the bilateral agreements with each of the provinces and territories. The funding is available now for them to start their projects immediately.
We have made important investments in infrastructure in every region. Our goal remains to work collaboratively, responsibly and quickly to invest in infrastructure. However, the application process is critical and it is incumbent on all of us to ensure these investments will make the lives of Canadians better.
My colleague commented about the weather. This winter, Newfoundland and Labrador has seen mountains of snow and I know it will have an impact on its construction season as well. I agree with the member that we need to do all we can to ensure we get the funding out to the respective communities in a timely manner.
View Ken McDonald Profile
Lib. (NL)
View Ken McDonald Profile
2020-03-10 11:54 [p.1859]
Madam Speaker, the member of the NDP mentioned a couple of things of interest. One was he mentioned the original status of the trade agreement and that leaving it as it is probably would not have been a bad thing. Has he forgotten about the tariffs that were imposed under that trade agreement, with its lack of defining things? There were the tariffs that were put on aluminum, that were put on steel, that were put on wood products, paper and whatnot. He has forgotten that.
The member mentioned the corporate free trade deal. A lot of the corporations that are in favour of this trade deal employ hundreds of thousands of people across this country, many of them unionized employees, to their benefit. In my riding, Ocean Choice International applauds the trade agreement because it enables the company to open markets free of tariffs and to provide well-paying jobs to the people who work for that company. Can the member say whether he still supports that, or whether he would just as soon those corporations did not have that ability in those free trade agreements?
View Ken McDonald Profile
Lib. (NL)
View Ken McDonald Profile
2020-03-09 14:10 [p.1796]
Mr. Speaker, it is a tale as old as time: Alberta and Newfoundland and Labrador. It is usually a story of two friends. However, last night it was a battle of the rocks of the rings for the 2020 Tim Hortons Brier. Team Gushue, Olympic gold medallists, two-time world champions, three-time Brier winners and the pride of the Rock, took home the 2020 Brier in a nearly perfect seven to three win over Team Alberta. Mark Nichols, Brett Gallant, Geoff Walker and our boy Brad Gushue brought home the Brier cup to where it rightfully belongs, settling yet another rivalry once and for all.
As we watched from home, the crowd cheering and celebrating along with the team in Kingston, Ontario, last night, we could have sworn they were back home at Mile One stadium in St. John's with their hometown crowd. Newfoundlanders and Labradorians are proud to be a part of Team Gushue and we are certainly proud to call them our own.
“Congratulations, hurry home and, as always, hurry, hurry hard.”
View Seamus O'Regan Profile
Lib. (NL)
Mr. Speaker, growing our economy and protecting the environment is important work that transcends any single project. Our government is committed to working with Alberta and the energy resource sector to move good projects forward.
Results: 1 - 15 of 66 | Page: 1 of 5

1
2
3
4
5
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data